Table 3 Comparisons of pathological characteristics between diabetic group and non-diabetic group
Characteristic | Diabetic group (n = 72) [%] | Non-diabetic group (n = 144) [%] | χ2 | P value |
|---|---|---|---|---|
T stage | ||||
 T1 | 16 (22.2) | 36 (25.0) | 0.809 | 0.667 |
 T2 | 35 (48.6) | 74 (51.4) |  |  |
 T3 | 21 (29.2) | 34 (23.6) |  |  |
Axillary lymph nodes | ||||
 Positive | 45 (62.5) | 75 (52.1) | 2.109 | 0.146 |
 Negative | 27 (37.5) | 69 (47.9) |  |  |
Pathological types | ||||
 Invasive ductal carcinoma | 66 (91.7) | 136 (94.4) | 0.890 | 0.828 |
 Invasive lobular carcinoma | 3 (4.2) | 3 (2.1) |  |  |
 Invasive papilloma | 2 (2.8) | 3 (2.1) |  |  |
 Mucinous adenocarcinoma | 1 (1.4) | 2 (1.4) |  |  |
Tumor stage | ||||
 I | 4 (5.6) | 19 (13.2) | 2.966 | 0.227 |
 II | 27 (37.5) | 51 (35.4) |  |  |
 III | 41 (56.9) | 74 (51.4) |  |  |
Histological grade | ||||
 WHO I | 5 (6.9) | 9 (6.2) | 2.099 | 0.350 |
 WHO II | 42 (58.3) | 98 (68.1) |  |  |
 WHO III | 25 (34.7) | 37 (25.7) |  |  |
Lymph node metastasis | ||||
 Positive | 45 (62.5) | 55 (38.2) | 11.410 | <0.001 |
 Negative | 27 (37.5) | 89 (61.8) |  |  |
ER | ||||
 Positive | 42 (58.3) | 88 (61.1) | 0.155 | 0.694 |
 Negative | 30 (41.7) | 56 (38.9) |  |  |
PR | ||||
 Positive | 40 (55.6) | 91 (63.2) | 1.174 | 0.279 |
 Negative | 32 (44.4) | 53 (36.8) |  |  |
Her-2 | ||||
 Positive | 25 (34.7) | 66 (458) | 2.431 | 0.119 |
 Negative | 47 (65.3) | 78 (54.2) |  |  |
P-gp | ||||
 Positive | 60 (83.3) | 121 (84.0) | 0.017 | 0.896 |
 Negative | 12 (16.7) | 23 (16.0) |  |  |
Topo-II | ||||
 Positive | 64 (88.9) | 132 (91.7) | 0.441 | 0.507 |
 Negative | 8 (11.1) | 12 (8.3) |  |  |
Gst-Ï€ | ||||
 Positive | 39 (54.2) | 70 (48.6) | 0.593 | 0.441 |
 Negative | 33 (45.8) | 74 (51.4) |  |  |